ClinicalTrials.Veeva

Menu

Protein Digestion After Bariatric Surgery in Older Adults (ProDigBO)

U

Universitaire Ziekenhuizen KU Leuven

Status

Enrolling

Conditions

Aging
Bariatric Surgery Candidate
Overweight and Obesity
Protein Malabsorption

Treatments

Other: Dual isotope protein digestibility method

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this clinical trial is to investigate protein digestibility after bariatric surgery.

Does protein digestibility decrease after Roux-en-Y-Gastric Bypass? Does protein digestibility decrease after Sleeve Gastrectomy surgery? Does protein digestibility effect the ability to meet protein requirements?

Full description

Purpose of clinical trial is to investigate the digestion of dietary protein in older patients who have undergone Roux-and-Y Bypass (RYGB) or sleeve gastrectomy (SG) surgery. The primary objective is to compare dietary protein digestion during a test meal who have previously undergone a RYGB surgery, SG surgery, or control patients, using a dual stable-isotope method. The secondary objectives are to investigate the relationship between protein intake corrected for protein digestion and skeletal muscle mass, and to investigate the relationship between the rate of free amino acid appearance and protein digestion.

Enrollment

72 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Signed informed consent
  • Group 1,2,3: Age 65 years or older
  • Group 4,5,6: Age 18 to 65 years
  • Group 1,2,4,5: Previous bariatric surgery for obesity 1 - 10 years ago
  • Group 3,6: No previous weight loss surgery

Exclusion criteria

  • Current diagnosis of cancer
  • Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Stage 3, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4.
  • Immobility
  • Neuromuscular degenerative conditions
  • Gastrointestinal conditions including coeliac disease, Crohn's disease, previous resection of the small intestine, gastroparesis
  • Unable to follow the procedures of the studies due to cognitive impairment such as diagnosed dementia.
  • Allergy/intolerance to milk, or soy or spirulina

Trial design

72 participants in 6 patient groups

Group 1: Patients over 65 years of age who had undergone Roux-en-Y bariatric surgery
Description:
Group 1: Patients over 65 years of age who had undergone Roux-en-Y bariatric surgery
Treatment:
Other: Dual isotope protein digestibility method
Group 2: Patients over 65 years of age who had undergone sleeve gastrectomy surgery
Description:
Group 2: Patients over 65 years of age who had undergone sleeve gastrectomy surgery
Treatment:
Other: Dual isotope protein digestibility method
Group 3: Patients over 65 years of age without previous bariatric surgery
Description:
Group 3: Patients over 65 years of age without previous bariatric surgery
Treatment:
Other: Dual isotope protein digestibility method
Group 4: Patients younger than 65 years of age who had undergone Roux-en-Y bariatric surgery
Description:
Group 4: Patients younger than 65 years of age who had undergone Roux-en-Y bariatric surgery
Treatment:
Other: Dual isotope protein digestibility method
Group 5: Patients younger than 65 years of age who had undergone Sleeve Gastrectomy
Description:
Group 5: Patients younger than 65 years of age who had undergone Sleeve Gastrectomy
Treatment:
Other: Dual isotope protein digestibility method
Group 6: Patients younger then 65 years of age without previous bariatric surgery
Description:
Group 6: Patients younger then 65 years of age without previous bariatric surgery
Treatment:
Other: Dual isotope protein digestibility method

Trial contacts and locations

2

Loading...

Central trial contact

Gabriel Eksteen, MSc; Bart Van der Schueren

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems